Skip to main content UVA Health logo of UVA Health
May 12, 2020


placeholder image

Dorian A Rosen, PhD, (left) and Alban Gaultier, PhD, found last year that fluvoxamine may stop the deadly inflammation known as sepsis. The drug is now being tested as a protective measure for patients with COVID-19.

Media Contact
Joshua Barney

Deputy Public Information Officer

Email  |

Phone  |  434.906.8864

Latest News